Illumina (ILMN) and Thermo Fisher Scientific (TMO) both sell to drug developers and the labs that test patients, but they ...

Image source: The Motley Fool. Vice President, Investor Relations - Rafael Tejada Chairman and Chief Executive Officer - Marc ...

Shares of Thermo Fisher Scientific (TMO) gained on Wednesday after the life sciences company raised its full-year outlook, reporting better-than-expected financials for Q3 2026, thanks mainly to its ...

Thermo Fisher Scientific Inc. shows 6% organic growth, margin expansion, and rising FCF. Click for this TMO earnings update.

Thermo Fisher Scientific delivered strong Q3 results, with 6% organic growth, EPS and sales beats, and raised full-year ...

Life sciences company Thermo Fisher (NYSE:TMO) reported Q3 2026 results , with sales up 9.1% year on year to $12.14 billion.

Thermo Fisher Scientific, a global leader in scientific instrumentation and software, has reported another impressive quarter ...

Thermo Fisher Scientific Inc. posted better-than-expected results for the third quarter of 2026, with adjusted earnings of $6 ...

TD Cowen raised its Thermo Fisher target from USD 675 to USD 760 on October 13, 2026. Thermo Fisher's third-quarter results ...

Thermo Fisher beat on both lines with adjusted operating margin widening 120 basis points to 24.5%. Updated full-year ...

Thermo Fisher Scientific Inc. reported third-quarter 2026 results on October 21, 2026, with revenue up 9 percent to USD 12.14 ...

Thermo Fisher Scientific reported higher profit and revenue in the latest quarter, boosted in part by new product launches. The scientific instruments company posted a third-quarter profit of $1.72 ...